全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

虾青素在中毒性肝损伤中作用的研究进展
Research Progress on the Role of Astaxanthin in Toxic Liver Injury

DOI: 10.12677/acm.2024.1461965, PP. 1686-1693

Keywords: 虾青素,中毒性肝损伤,氧化应激,炎症反应
Astaxanthin
, Toxic Liver Injury, Oxidative Stress, Inflammatory Reaction

Full-Text   Cite this paper   Add to My Lib

Abstract:

中毒性肝损伤指各种药物、毒物及其代谢产物引起的肝脏损伤性病变。其病因繁多,机制复杂、病情进展迅速,病死率高,越来越受到人们的关注,寻找能够有效治疗肝脏疾病的解毒药物显得尤为重要。虾青素是一种脂溶性类胡萝卜素,广泛分布在海洋藻类、菌类和甲壳类动物中,研究表明,虾青素在抗氧化、抗炎、免疫调节、抑制细胞凋亡、抑制肝纤维化等方面对肝损伤具有显著作用,本文就虾青素在中毒性肝损伤的研究现状展开综述,以期为虾青素的进一步研究及中毒性肝损伤的新药研发提供新的思路。
Toxic liver injury refers to liver injury caused by various drugs, poisons and their metabolites. With various etiology, complex mechanism, rapid progression and high fatality rate, it has attracted more and more attention. It is particularly important to find detoxification drugs that can effectively treat liver diseases. Astaxanthin is a kind of lipid soluble carotenoid, widely distributed in Marine algae, fungi and crustaceans. Studies have shown that astaxanthin has significant effects on acute liver injury in antioxidant, anti-inflammatory, immune regulation, inhibition of apoptosis, inhibition of liver fibrosis and other aspects. This paper reviews the research status of astaxanthin in toxic liver injury, in order to provide new ideas for further study of astaxanthin and new drug development of toxic liver injury.

References

[1]  温韬, 赵金垣. 中毒性肝损伤发病机制的研究动态[J]. 中国工业医学杂志, 2009, 22(6): 434-438.
[2]  Frenzel, C. and Teschke, R. (2016) Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences, 17, Article 588.
https://doi.org/10.3390/ijms17050588
[3]  Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M.I. and Andrade, R.J. (2020) Drug Induced Liver Injury: An Update. Archives of Toxicology, 94, 3381-3407.
https://doi.org/10.1007/s00204-020-02885-1
[4]  Li, J., Guo, C. and Wu, J. (2020) Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug Design, Development and Therapy, 14, 2275-2285.
https://doi.org/10.2147/dddt.s230749
[5]  胡艺琪, 史瑞雅, 陈佳音, 等. 虾青素临床研究现状及其在特医食品开发中的应用前景[J]. 中国海洋药物, 2022, 41(4): 89-94.
[6]  余小元, 谢子健, 曹月琴, 等. 虾青素的主要来源物种——雨生红球藻[J]. 生物学通报, 2022, 57(2): 7-11.
[7]  Lorenz, R.T. and Cysewski, G.R. (2000) Commercial Potential for Haematococcus Microalgae as a Natural Source of Astaxanthin. Trends in Biotechnology, 18, 160-167.
https://doi.org/10.1016/s0167-7799(00)01433-5
[8]  Stachowiak, B. and Szulc, P. (2021) Astaxanthin for the Food Industry. Molecules, 26, Article 2666.
https://doi.org/10.3390/molecules26092666
[9]  Naguib, Y.M.A. (2000) Antioxidant Activities of Astaxanthin and Related Carotenoids. Journal of Agricultural and Food Chemistry, 48, 1150-1154.
https://doi.org/10.1021/jf991106k
[10]  Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher-Shahri, A.M. and Samarghandian, S. (2022) Anti-Inflammatory Action of Astaxanthin and Its Use in the Treatment of Various Diseases. Biomedicine & Pharmacotherapy, 145, Article ID: 112179.
https://doi.org/10.1016/j.biopha.2021.112179
[11]  Nakagawa, K., Kiko, T., Miyazawa, T., Carpentero Burdeos, G., Kimura, F., Satoh, A., et al. (2011) Antioxidant Effect of Astaxanthin on Phospholipid Peroxidation in Human Erythrocytes. British Journal of Nutrition, 105, 1563-1571.
https://doi.org/10.1017/s0007114510005398
[12]  陆婵君, 郭艺, 胡可, 等. 虾青素调控Nrf2通路发挥心血管保护作用的研究进展[J]. 中国新药与临床杂志, 2023, 42(5): 284-288.
[13]  Li, H., Li, J., Hou, C., Li, J., Peng, H. and Wang, Q. (2020) The Effect of Astaxanthin on Inflammation in Hyperosmolarity of Experimental Dry Eye Model in Vitro and in Vivo. Experimental Eye Research, 197, Article ID: 108113.
https://doi.org/10.1016/j.exer.2020.108113
[14]  Cui, L., Xu, F., Wang, M., Li, L., Qiao, T., Cui, H., et al. (2019) Dietary Natural Astaxanthin at an Early Stage Inhibits N-Nitrosomethylbenzylamine-Induced Esophageal Cancer Oxidative Stress and Inflammation via Downregulation of NFκB and COX2 in F344 Rats. OncoTargets and Therapy, 12, 5087-5096.
https://doi.org/10.2147/ott.s197044
[15]  中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 中华医学会全科医学分会, 中华医学会《中华全科医师杂志》编辑委员会, 消化系统疾病基层诊疗指南编写专家组. 药物性肝损伤基层诊疗指南(2019年) [J].中华全科医师杂志, 2020, 19(10): 868-875.
[16]  章晨怡, 茹清静. 浅议“药毒”与药物性肝损伤[J]. 中西医结合肝病杂志, 2020, 30(2): 179-181.
[17]  朱蓉蓉, 谢治强, 马瑞萍. 药物性肝损伤研究现状[J]. 社区医学杂志, 2023, 21(10): 535-539.
[18]  卢伟, 潘梦, 方亦可, 等. 中药治疗急性肝损伤作用机制研究进展[J]. 中南药学, 2019, 17(9): 1504-1507.
[19]  Stravitz, R.T. and Lee, W.M. (2019) Acute Liver Failure. The Lancet, 394, 869-881.
https://doi.org/10.1016/s0140-6736(19)31894-x
[20]  Moles, A., Torres, S., Baulies, A., Garcia-Ruiz, C. and Fernandez-Checa, J.C. (2018) Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity. Frontiers in Pharmacology, 9, Article 453.
https://doi.org/10.3389/fphar.2018.00453
[21]  da Rocha, B.A., Ritter, A.M.V., Ames, F.Q., Gon?alves, O.H., Leimann, F.V., Bracht, L., et al. (2017) Acetaminophen-induced Hepatotoxicity: Preventive Effect of Trans Anethole. Biomedicine & Pharmacotherapy, 86, 213-220.
https://doi.org/10.1016/j.biopha.2016.12.014
[22]  Yan, M., Huo, Y., Yin, S. and Hu, H. (2018) Mechanisms of Acetaminophen-Induced Liver Injury and Its Implications for Therapeutic Interventions. Redox Biology, 17, 274-283.
https://doi.org/10.1016/j.redox.2018.04.019
[23]  Jaeschke, H., Akakpo, J.Y., Umbaugh, D.S. and Ramachandran, A. (2020) Novel Therapeutic Approaches against Acetaminophen-Induced Liver Injury and Acute Liver Failure. Toxicological Sciences, 174, 159-167.
https://doi.org/10.1093/toxsci/kfaa002
[24]  Cai, X., Hua, S., Deng, J., Du, Z., Zhang, D., Liu, Z., et al. (2022) Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury. ACS Applied Materials & Interfaces, 14, 42887-42903.
https://doi.org/10.1021/acsami.2c10506
[25]  Mohan, M., Kamble, S., Gadhi, P. and Kasture, S. (2010) Protective Effect of Solanum Torvum on Doxorubicin-Induced Nephrotoxicity in Rats. Food and Chemical Toxicology, 48, 436-440.
https://doi.org/10.1016/j.fct.2009.10.042
[26]  Ma, H., Chen, S., Xiong, H., Wang, M., Hang, W., Zhu, X., et al. (2020) Astaxanthin from Haematococcus pluvialis Ameliorates the Chemotherapeutic Drug (Doxorubicin) Induced Liver Injury through the Keap1/Nrf2/HO-1 Pathway in Mice. Food & Function, 11, 4659-4671.
https://doi.org/10.1039/c9fo02429h
[27]  Belfayol-Pisanté, L., Guillevin, L., Tod, M. and Fauvelle, F. (2000) Pharmacokinetics of Cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in Systemic Vasculitis. Fundamental & Clinical Pharmacology, 14, 415-421.
https://doi.org/10.1111/j.1472-8206.2000.tb00424.x
[28]  Zhong, S., Huang, M., Yang, X., Liang, L., Wang, Y., Romkes, M., et al. (2006) Relationship of Glutathione S-Transferase Genotypes with Side-effects of Pulsed Cyclophosphamide Therapy in Patients with Systemic Lupus Erythematosus. British Journal of Clinical Pharmacology, 62, 457-472.
https://doi.org/10.1111/j.1365-2125.2006.02690.x
[29]  Tripathi, D.N. and Jena, G.B. (2010) Astaxanthin Intervention Ameliorates Cyclophosphamide-Induced Oxidative Stress, DNA Damage and Early Hepatocarcinogenesis in Rat: Role of Nrf2, P53, P38 and Phase-Ii Enzymes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 696, 69-80.
https://doi.org/10.1016/j.mrgentox.2009.12.014
[30]  邓亮, 徐可树. 中毒性肝病诊治的相关问题[J]. 中国临床医生, 2014, 42(10): 14-17.
[31]  Ohta, Y., Kongo-Nishimura, M., Matsura, T., Yamada, K., Kitagawa, A. and Kishikawa, T. (2003) Melatonin Prevents Disruption of Hepatic Reactive Oxygen Species Metabolism in Rats Treated with Carbon Tetrachloride. Journal of Pineal Research, 36, 10-17.
https://doi.org/10.1046/j.1600-079x.2003.00091.x
[32]  Zhang, C., Han, C., Zhao, B. and Yu, H. (2012) The Protective Effects of Aqueous Extracts of Wild-Growing and Fermented Royal Sun Mushroom, Agaricus brasiliensis S. Wasser et al. (Higher Basidiomycetes), in CCl4-Induced Oxidative Damage in Rats. International Journal of Medicinal Mushrooms, 14, 557-561.
https://doi.org/10.1615/intjmedmushr.v14.i6.30
[33]  Ohta, Y., Imai, Y., Matsura, T., Kitagawa, A. and Yamada, K. (2006) Preventive Effect of Neutropenia on Carbon Tetrachloride-Induced Hepatotoxicity in Rats. Journal of Applied Toxicology, 26, 178-186.
https://doi.org/10.1002/jat.1122
[34]  Kang, J.O., Kim, S.J. and Kim, H. (2001) Effect of Astaxanthin on the Hepatotoxicity, Lipid Peroxidation and Antioxidative Enzymes in the Liver of CCl4-Treated Rats. Methods and Findings in Experimental and Clinical Pharmacology, 23, 79.
https://doi.org/10.1358/mf.2001.23.2.627931
[35]  Alam, M.A., Islam, M.A., Al Mamun, M.A., Faruk, M., Ul Islam, M.T., Rahman, M.M., et al. (2017) Astaxanthin Ameliorates Hepatic Damage and Oxidative Stress in Carbon Tetrachloride-Administered Rats. Pharmacognosy Research, 9, s84-s91.
https://doi.org/10.4103/pr.pr_26_17
[36]  Lee, J.Y. and Hwang, D.H. (2006) The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-Like Receptors. Molecules and Cells, 21, 174-185.
https://doi.org/10.1016/s1016-8478(23)12877-9
[37]  Du, L., Zheng, Y., Yang, Y., Huang, Y., Hao, Y., Chen, C., et al. (2022) Krill Oil Prevents Lipopolysaccharide-Evoked Acute Liver Injury in Mice through Inhibition of Oxidative Stress and Inflammation. Food & Function, 13, 3853-3864.
https://doi.org/10.1039/d1fo04136c
[38]  Zhang, Z., Guo, C., Jiang, H., Han, B., Wang, X., Li, S., et al. (2020) Inflammation Response after the Cessation of Chronic Arsenic Exposure and Post-Treatment of Natural Astaxanthin in Liver: Potential Role of Cytokine-Mediated Cell-Cell Interactions. Food & Function, 11, 9252-9262.
https://doi.org/10.1039/d0fo01223h
[39]  陈金丽. 虾青素对牛黄解毒片所致小鼠肝脏损伤的保护作用及其可能机制[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2018.
[40]  Xu, L., Xu, X., Guo, L., Wang, Z., Wu, X., Kuang, H., et al. (2021) Potential Environmental Health Risk Analysis of Neonicotinoids and a Synergist. Environmental Science & Technology, 55, 7541-7550.
https://doi.org/10.1021/acs.est.1c00872
[41]  Sarιkaya, R., Sepici-Din?el, A., ?a?lan Karasu Benli, A., Selvi, M. and Erko?, F. (2010) The Acute Toxicity of Fenitrothion on Narrow-Clawed Crayfish (Astacus leptodactylus Eschscholtz, 1823) in Association with Biomarkers of Lipid Peroxidation. Journal of Biochemical and Molecular Toxicology, 25, 169-174.
https://doi.org/10.1002/jbt.20373
[42]  Abou-Zeid, S.M., Aljuaydi, S.H., AbuBakr, H.O., Tahoun, E.A., Di Cerbo, A., Alagawany, M., et al. (2021) Astaxanthin Mitigates Thiacloprid-Induced Liver Injury and Immunotoxicity in Male Rats. Marine Drugs, 19, Article 525.
https://doi.org/10.3390/md19090525
[43]  Gradelet, S., Astorg, P., Le Bon, A., Bergès, R. and Suschetet, M. (1997) Modulation of Aflatoxin B1 Carcinogenicity, Genotoxicity and Metabolism in Rat Liver by Dietary Carotenoids: Evidence for a Protective Effect of CYP1A Inducers. Cancer Letters, 114, 221-223.
https://doi.org/10.1016/s0304-3835(97)04668-5
[44]  Monmeesil, P., Fungfuang, W., Tulayakul, P. and Pongchairerk, U. (2019) The Effects of Astaxanthin on Liver Histopathology and Expression of Superoxide Dismutase in Rat Aflatoxicosis. Journal of Veterinary Medical Science, 81, 1162-1172.
https://doi.org/10.1292/jvms.18-0690
[45]  Tian, Y., Che, H., Yang, J., Jin, Y., Yu, H., Wang, C., et al. (2023) Astaxanthin Alleviates Aflatoxin B1-Induced Oxidative Stress and Apoptosis in IPEC-J2 Cells via the Nrf2 Signaling Pathway. Toxins, 15, Article 232.
https://doi.org/10.3390/toxins15030232
[46]  Jaurigue, M.M. (2014) Therapy for Alcoholic Liver Disease. World Journal of Gastroenterology, 20, 2143-2158.
https://doi.org/10.3748/wjg.v20.i9.2143
[47]  Hosseini, N., Shor, J. and Szabo, G. (2019) Alcoholic Hepatitis: A Review. Alcohol and Alcoholism, 54, 408-416.
https://doi.org/10.1093/alcalc/agz036
[48]  Dunn, W. and Shah, V.H. (2016) Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease, 20, 445-456.
https://doi.org/10.1016/j.cld.2016.02.004
[49]  Yan, J., Nie, Y., Luo, M., Chen, Z. and He, B. (2021) Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Frontiers in Pharmacology, 12, Article 694475.
https://doi.org/10.3389/fphar.2021.694475
[50]  Liu, H., Liu, M., Fu, X., Zhang, Z., Zhu, L., Zheng, X., et al. (2018) Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota. Nutrients, 10, Article 1298.
https://doi.org/10.3390/nu10091298

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133